Rapacuronium: premarket drug evaluation can be very effective for the identification of drug risks

Anesth Analg. 2003 Feb;96(2):631-2. doi: 10.1097/00000539-200302000-00070.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bronchial Spasm / chemically induced
  • Bronchial Spasm / epidemiology
  • Bronchial Spasm / physiopathology
  • Humans
  • Neuromuscular Nondepolarizing Agents / adverse effects*
  • United States
  • United States Food and Drug Administration
  • Vecuronium Bromide / adverse effects*
  • Vecuronium Bromide / analogs & derivatives*

Substances

  • Neuromuscular Nondepolarizing Agents
  • Vecuronium Bromide
  • rapacuronium